AstraZeneca completes Fusion Pharmaceuticals acquisition

AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.

Jun 6, 2024 - 04:00

AstraZeneca completes Fusion Pharmaceuticals acquisition

AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.

Read the original article

Tags:

Previous Article

J&J seeks expanded approvals for paediatric HIV-1 therapy

Climate change may aggravate multiple sclerosis

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

STAT+: Merck CEO refused to testify in Senate because h...

Jan 28, 2024

STAT+: With new acquisitions, Humana and CVS hope to turn members into patients

STAT+: With new acquisitions, Humana and CVS hope to tu...

Aug 3, 2023

AstraZeneca posts 81% rise in FY 2023 profit after tax

AstraZeneca posts 81% rise in FY 2023 profit after tax

Feb 10, 2024